The company is exploring the efficacy of Otezla as a potential treatment for pulmonary distress associated with COVID-19.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
